{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:38:15Z","timestamp":1767793095397,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,7]]},"DOI":"10.7759\/cureus.100980","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T10:03:02Z","timestamp":1767780182000},"source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Early Anticoagulation Therapy in Acute Pulmonary Embolism: A Retrospective Cohort Study in the Emergency Department"],"prefix":"10.7759","author":[{"given":"Amna","family":"Riaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qasim","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunnia","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz Usman","family":"Khalid Ranjha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesam Taher","family":"Almagharbeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawson O","family":"Obazenu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0959","article-title":"Early anticoagulation is associated with reduced mortality for acute pulmonary embolism","volume":"137","author":"Smith SB","year":"2010","unstructured":"Smith SB, Geske JB, Maguire JM, Zane NA, Carter RE, Morgenthaler TI. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest. 2010, 137:1382-90. 10.1378\/chest.09-0959","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-024-00631-6","article-title":"Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism","volume":"22","author":"Hayashi H","year":"2024","unstructured":"Hayashi H, Tsuji A, Kotoku A, et al.. Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism. Thromb J. 2024, 22:60. 10.1186\/s12959-024-00631-6","journal-title":"Thromb J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/acem.13872","article-title":"Analysis of partial thromboplastin times in patients with pulmonary embolism during the first 48 hours of anticoagulation with unfractionated heparin","volume":"27","author":"Prucnal CK","year":"2020","unstructured":"Prucnal CK, Jansson PS, Deadmon E, Rosovsky RP, Zheng H, Kabrhel C. Analysis of partial thromboplastin times in patients with pulmonary embolism during the first 48 hours of anticoagulation with unfractionated heparin. Acad Emerg Med. 2020, 27:117-27. 10.1111\/acem.13872","journal-title":"Acad Emerg Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2007.10.004","article-title":"Increased diagnosis of pulmonary embolism without a corresponding decline in mortality during the CT era","volume":"63","author":"Burge AJ","year":"2008","unstructured":"Burge AJ, Freeman KD, Klapper PJ, Haramati LB. Increased diagnosis of pulmonary embolism without a corresponding decline in mortality during the CT era. Clin Radiol. 2008, 63:381-6. 10.1016\/j.crad.2007.10.004","journal-title":"Clin Radiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14207","article-title":"Anti-factor Xa as the preferred assay to monitor heparin for the treatment of pulmonary embolism","volume":"46","author":"Zhu E","year":"2024","unstructured":"Zhu E, Yuriditsky E, Raco V, et al.. Anti-factor Xa as the preferred assay to monitor heparin for the treatment of pulmonary embolism. Int J Lab Hematol. 2024, 46:354-61. 10.1111\/ijlh.14207","journal-title":"Int J Lab Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2007.03.028","article-title":"Prognostic significance of delays in diagnosis of pulmonary embolism","volume":"121","author":"Jim\u00e9nez Castro D","year":"2007","unstructured":"Jim\u00e9nez Castro D, Sueiro A, D\u00edaz G, et al.. Prognostic significance of delays in diagnosis of pulmonary embolism. Thromb Res. 2007, 121:153-8. 10.1016\/j.thromres.2007.03.028","journal-title":"Thromb Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob GE","year":"2018","unstructured":"Raskob GE, Van Es N, Verhamme P, et al.. Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med. 2018, 378:615-24. 10.1056\/NEJMoa1711948","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn208","article-title":"Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review","volume":"29","author":"Sanchez O","year":"2008","unstructured":"Sanchez O, Trinquart L, Colombet I, Durieux P, Huisman MV, Chatellier G, Meyer G. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J. 2008, 29:1569-77. 10.1093\/eurheartj\/ehn208","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000100687.99687","article-title":"Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism","volume":"4","author":"Kucher N","year":"2003","unstructured":"Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation. 2003, 4:2191-4. 10.1161\/01.CIR.0000100687.99687","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt DM","year":"2018","unstructured":"Witt DM, Nieuwlaat R, Clark NP, et al.. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018, 2:3257-91. 10.1182\/bloodadvances.2018024893","journal-title":"Blood Adv"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001100.pub4","article-title":"Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism","volume":"2","author":"Robertson L","year":"2017","unstructured":"Robertson L, Jones LE. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. Cochrane Database Syst Rev. 2017, 2:CD001100. 10.1002\/14651858.CD001100.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.52877","article-title":"Factors in initial anticoagulation choice in hospitalized patients with pulmonary embolism","volume":"8","author":"Stubblefield WB","year":"2025","unstructured":"Stubblefield WB, Helderman R, Strokes N, Greineder CF, Barnes GD, Vinson DR, Westafer LM. Factors in initial anticoagulation choice in hospitalized patients with pulmonary embolism. JAMA Netw Open. 2025, 8:e2452877. 10.1001\/jamanetworkopen.2024.52877","journal-title":"JAMA Netw Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.09.027","article-title":"Moderate pulmonary embolism treated with thrombolysis (from the \"MOPETT\" Trial)","volume":"111","author":"Sharifi M","year":"2013","unstructured":"Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. Moderate pulmonary embolism treated with thrombolysis (from the \"MOPETT\" Trial). Am J Cardiol. 2013, 111:273-7. 10.1016\/j.amjcard.2012.09.027","journal-title":"Am J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-015-1314-3","article-title":"Pharmacology of anticoagulants used in the treatment of venous thromboembolism","volume":"41","author":"Nutescu EA","year":"2016","unstructured":"Nutescu EA, Burnett A, Fanikos J, Spinler S, Wittkowsky A. Pharmacology of anticoagulants used in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016, 41:15-31. 10.1007\/s11239-015-1314-3","journal-title":"J Thromb Thrombolysis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides SV","year":"2020","unstructured":"Konstantinides SV, Meyer G, Becattini C, et al.. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020, 41:543-603. 10.1093\/eurheartj\/ehz405","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-17-1128","article-title":"Anticoagulation therapy for venous thromboembolism in the real world-from the COMMAND VTE Registry","volume":"82","author":"Yamashita Y","year":"2018","unstructured":"Yamashita Y, Morimoto T, Amano H, et al.. Anticoagulation therapy for venous thromboembolism in the real world-from the COMMAND VTE Registry. Circ J. 2018, 82:1262-70. 10.1253\/circj.CJ-17-1128","journal-title":"Circ J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13340","article-title":"Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?","volume":"83","author":"Leentjens J","year":"2017","unstructured":"Leentjens J, Peters M, Esselink AC, Smulders Y, Kramers C. Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?. Br J Clin Pharmacol. 2017, 83:2356-66. 10.1111\/bcp.13340","journal-title":"Br J Clin Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12245-025-00941-0","article-title":"Life-threatening recurrent pulmonary embolism following anticoagulation withdrawal: a case report emphasising the management dilemma in resource-constrained settings","volume":"18","author":"Raharjo PP","year":"2025","unstructured":"Raharjo PP, Wiyono AV, Panjaitan U, Putra IC, Hermanto K, Dewi TI, Pramudyo M. Life-threatening recurrent pulmonary embolism following anticoagulation withdrawal: a case report emphasising the management dilemma in resource-constrained settings. Int J Emerg Med. 2025, 18:145. 10.1186\/s12245-025-00941-0","journal-title":"Int J Emerg Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146733","article-title":"Pulmonary embolism in acute ischaemic stroke: evolving evidence, diagnostic challenges, and a novel thromboinflammatory axis hypothesis","volume":"26","author":"Chen D","year":"2025","unstructured":"Chen D, Bhaskar SM. Pulmonary embolism in acute ischaemic stroke: evolving evidence, diagnostic challenges, and a novel thromboinflammatory axis hypothesis. Int J Mol Sci. 2025, 26:6733. 10.3390\/ijms26146733","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/438573-the-effect-of-early-anticoagulation-therapy-in-acute-pulmonary-embolism-a-retrospective-cohort-study-in-the-emergency-department","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T10:03:02Z","timestamp":1767780182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/438573-the-effect-of-early-anticoagulation-therapy-in-acute-pulmonary-embolism-a-retrospective-cohort-study-in-the-emergency-department"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.100980","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,7]]}}}